Houma Doctor Charged with Distributing Misbranded Injectable Contraceptives to Patients

NEW ORLEANS – U.S. Attorney Duane A. Evans announced today that MICHELLE ANDRE, age 48, a physician residing in Houma, La. was charged on January 9, 2024 with  distribution of misbranded drugs, in violation of 21 U.S.C. § 331.

According to court documents, from April 2018 through March 2023, ANDRE introduced misbranded drugs, including medroxyprogesterone, into interstate commerce.  The medroxyprogesterone lacked adequate directions for use in its labeling.  

If convicted, ANDRE faces  up to one year in prison and up to one year of supervised release.

U.S. Attorney Evans praised the work of the Food and Drug Administration. Assistant United States Attorneys Rachal Cassagne of the Narcotics Unit and Paul Hubbell of the General Crimes Unit are in charge of the prosecution.